AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate
AbbVie stock surged early Friday after beating fourth-quarter expectations, largely on the back of its immunology drugs.
MarketWatch21h
S&P 500 Information Technology Sector Index
IPC Indice de Precios Y Cotizaciones 52,050.25 494.47 0.96% ...
MarketWatch21h
S&P 500 Pharmaceuticals Industry Index
IPC Indice de Precios Y Cotizaciones 52,050.25 494.47 0.96% ...
Fidelity International22h
Vanguard S&P 500 UCITS ETF (VUSA)
or substantially all, of its assets in the stocks that make up the Index, holding each stock in approximately the same proportion as its weighting in the Index. The Index is a capitalisation weighted ...
After the Fed meeting, what should you expect from your savings rates?
After the Fed cut rates three times in the second half of 2024, savings account interest rates started falling, and it doesn’t look like that will change anytime soon. But that doesn’t mean you’re out ...
This YouTuber just made the TikTok situation a lot more complicated
A well-known YouTuber has hinted at his interest in purchasing TikTok, making an already-complicated situation even murkier.
India's Vedanta beats Q3 core profit estimates on high metal prices
Indian miner Vedanta reported third-quarter core profit above market estimates on Friday, propelled by a strong showing in ...
Nationwide to acquire Allstate's stop-loss insurance business in $1.25 billion deal
The transaction is expected to close in the second half of 2025, Nationwide said in a statement. Ohio-based Nationwide is a ...
India's Jubilant Pharmova posts 51% jump in Q3 profit on strong demand
Consolidated net profit rose to 1.01 billion rupees ($11.7 million) in the quarter ended Dec. 31, from 668 million rupees a year ago. The drugmaker, which manufactures and supplies ...